Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-08
DOI
10.1038/s41419-022-05041-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
- (2021) Karen Slattery et al. Journal for ImmunoTherapy of Cancer
- An oncolytic virus expressing IL-15/IL-15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma
- (2021) Rui Ma et al. CANCER RESEARCH
- Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
- (2021) Sophie M. Poznanski et al. Cell Metabolism
- CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
- (2021) Takayuki Morimoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
- (2021) Shilpa Keerthivasan et al. IMMUNITY
- Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology
- (2021) Hyeon Joo Yoo et al. IMMUNOLOGIC RESEARCH
- The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia
- (2021) Xing-chen Ding et al. Journal of Hematology & Oncology
- Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
- (2021) Shee Kwan Phung et al. Molecular Diagnosis & Therapy
- T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1α Expression in Glioma
- (2021) Shuai Liu et al. Frontiers in Pharmacology
- Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
- (2021) Jiao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine-induced natural killer cell training is dependent on cellular metabolism and is defective in obesity
- (2021) Nidhi Kedia-Mehta et al. Blood Advances
- Tension in tumour cells keeps metabolism high
- (2020) Nadia M. E. Ayad et al. NATURE
- Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity
- (2020) Jing Ni et al. IMMUNITY
- HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
- (2020) Farzaneh Sharifzad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HLA‐DR‐expressing NK cells: Effective killers suspected for antigen presentation
- (2020) Sofya A. Erokhina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways
- (2020) Teru Hideshima et al. LEUKEMIA
- Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs
- (2020) Christian Bailly LIFE SCIENCES
- Multiplex digital spatial profiling of proteins and RNA in fixed tissue
- (2020) Christopher R. Merritt et al. NATURE BIOTECHNOLOGY
- Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
- (2020) Cavan P Bailey et al. NEURO-ONCOLOGY
- Editorial: Role of Metabolism in Regulating Immune Cell Fate Decisions
- (2020) Anna Ohradanova-Repic et al. Frontiers in Immunology
- Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
- (2020) Weilun Fu et al. Frontiers in Immunology
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
- (2020) Yufei Wang et al. Cells
- Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
- (2020) Wanzun Lin et al. Frontiers in Oncology
- A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
- (2020) Nancy L. Bartlett et al. BLOOD
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
- (2020) Kyle B. Lupo et al. Journal of Hematology & Oncology
- NK cells and ILCs in tumor immunotherapy
- (2020) Simona Sivori et al. MOLECULAR ASPECTS OF MEDICINE
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
- (2020) Kin Man Au et al. Science Advances
- Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
- (2020) Takumi Kobayashi et al. BLOOD
- CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions
- (2020) Bor-Ren Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
- (2020) David H. Peng et al. Nature Communications
- Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia
- (2020) Melissa M. Berrien-Elliott et al. Cancer Discovery
- NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
- (2020) Daniel A. Vallera et al. Cancers
- Investigating Glioblastoma Response to Hypoxia
- (2020) Agathe L. Chédeville et al. Biomedicines
- Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
- (2020) Lakshmi Nayak et al. CLINICAL CANCER RESEARCH
- Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: A systematic review
- (2020) Hao Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
- (2019) Locke D. Uppendahl et al. GYNECOLOGIC ONCOLOGY
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
- (2019) Pieter Goossens et al. Cell Metabolism
- HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
- (2019) Jason Miska et al. Cell Reports
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
- (2019) Yeon Ho Choi et al. Journal for ImmunoTherapy of Cancer
- Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity
- (2019) Angel G. Solis et al. NATURE
- Mechanosensing through immunoreceptors
- (2019) Cheng Zhu et al. NATURE IMMUNOLOGY
- Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation
- (2019) Leah Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion
- (2019) Andrew J. Freeman et al. Cell Reports
- NK Cell Dysfunction and Checkpoint Immunotherapy
- (2019) Jiacheng Bi et al. Frontiers in Immunology
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
- (2019) Kyohei Nakamura et al. Cellular & Molecular Immunology
- A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
- (2019) Emily J. Pomeroy et al. MOLECULAR THERAPY
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
- (2019) Fadi Jacob et al. CELL
- Metabolic control of B cell immune responses
- (2019) Julia Jellusova CURRENT OPINION IN IMMUNOLOGY
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Single-Cell Genomics: A Stepping Stone for Future Immunology Discoveries
- (2018) Amir Giladi et al. CELL
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways
- (2018) Xiaofan Guo et al. ONCOGENE
- Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
- (2018) Xiao-Yuan Mao et al. PHARMACOLOGY & THERAPEUTICS
- Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
- (2018) TOSHIHARU MURAKAMI et al. ANTICANCER RESEARCH
- Bevacizumab and Glioblastoma
- (2018) Michelle M. Kim et al. CANCER JOURNAL
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines
- (2017) Elena Ciaglia et al. INTERNATIONAL JOURNAL OF CANCER
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
- (2017) Nicole Colwell et al. NEURO-ONCOLOGY
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination?
- (2017) Harold R. Neely et al. Cold Spring Harbor Perspectives in Biology
- IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
- (2017) Margherita Boieri et al. OncoImmunology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing
- (2016) Roshni Basu et al. CELL
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Common gamma chain cytokines in combinatorial immune strategies against cancer
- (2016) Stephanie R. Pulliam et al. IMMUNOLOGY LETTERS
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells
- (2015) Mario Orozco-Morales et al. Cancer Cell International
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- The mechanical microenvironment in cancer: How physics affects tumours
- (2015) Anika Nagelkerke et al. SEMINARS IN CANCER BIOLOGY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Trafficking of T Cells into Tumors
- (2014) C. Y. Slaney et al. CANCER RESEARCH
- Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
- (2014) W. Cao et al. JOURNAL OF IMMUNOLOGY
- mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
- (2014) Raymond P. Donnelly et al. JOURNAL OF IMMUNOLOGY
- Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy
- (2014) Pedro R Lowenstein et al. OncoImmunology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression
- (2008) A. Ricciardi et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search